Sign inGet started

LBPH

Longboard Pharmaceuticals, Inc.CIK 1832168 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
11

AI insights for LBPH PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for LBPH
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Le Goff CorinneDirector10$0$02024-12-02
Lynch CaseyDirector10$0$02024-12-02
Lind Kevin RobertPresident and CEO17$0$02024-12-02
Aurentz VincentDirector10$0$02024-12-02
Roberts BrandiExecutive VP and CFO11$0$02024-12-02
Kaye RandallExecutive Vice President & CMO28$2.5K$2.09M2024-12-02
SEKHRI PAUL JDirector7$0$02024-12-02
SCHNEIDER PHILLIP MDirector7$0$02024-12-02
ARENA PHARMACEUTICALS INCOther3$0$96.48M2024-01-25
Tiller JaneDirector4$0$02023-05-25
Perera PhilipCMO1$0$02022-02-09

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Lind Kevin RobertPresident and CEO D To issuer deriv2024-12-022024-12-02332,134— $00SEC↗
Lind Kevin RobertPresident and CEO D To issuer deriv2024-12-022024-12-0222,000— $00SEC↗
Lind Kevin RobertPresident and CEO D To issuer deriv2024-12-022024-12-02255,377— $00SEC↗
Lind Kevin RobertPresident and CEO D To issuer deriv2024-12-022024-12-02325,850— $00SEC↗
Lind Kevin RobertPresident and CEO D To issuer deriv2024-12-022024-12-02192,783— $00SEC↗
Roberts BrandiExecutive VP and CFO D To issuer deriv2024-12-022024-12-0215,090— $00SEC↗
Roberts BrandiExecutive VP and CFO D To issuer deriv2024-12-022024-12-0290,580— $00SEC↗
Roberts BrandiExecutive VP and CFO D To issuer deriv2024-12-022024-12-02119,700— $00SEC↗
Roberts BrandiExecutive VP and CFO D To issuer deriv2024-12-022024-12-0290,000— $00SEC↗
Roberts BrandiExecutive VP and CFO D To issuer deriv2024-12-022024-12-02139,380— $00SEC↗
Roberts BrandiExecutive VP and CFO D To issuer deriv2024-12-022024-12-027,900— $00SEC↗
Kaye RandallExecutive Vice President & C D To issuer deriv2024-12-022024-12-029,500— $00SEC↗
Kaye RandallExecutive Vice President & C D To issuer deriv2024-12-022024-12-0217,920— $00SEC↗
Kaye RandallExecutive Vice President & C D To issuer deriv2024-12-022024-12-02175,946— $00SEC↗
Kaye RandallExecutive Vice President & C D To issuer deriv2024-12-022024-12-0296,300— $00SEC↗
Kaye RandallExecutive Vice President & C D To issuer deriv2024-12-022024-12-02107,560— $00SEC↗
Aurentz VincentDirector D To issuer deriv2024-12-022024-12-0222,500— $00SEC↗
Aurentz VincentDirector D To issuer deriv2024-12-022024-12-0212,500— $00SEC↗
Aurentz VincentDirector D To issuer deriv2024-12-022024-12-0212,367— $00SEC↗
Aurentz VincentDirector D To issuer deriv2024-12-022024-12-027,214— $00SEC↗
Aurentz VincentDirector D To issuer deriv2024-12-022024-12-0212,367— $00SEC↗
SCHNEIDER PHILLIP MDirector D To issuer deriv2024-12-022024-12-0212,500— $00SEC↗
SCHNEIDER PHILLIP MDirector D To issuer deriv2024-12-022024-12-0225,461— $00SEC↗
SCHNEIDER PHILLIP MDirector D To issuer deriv2024-12-022024-12-0212,367— $00SEC↗
SCHNEIDER PHILLIP MDirector D To issuer deriv2024-12-022024-12-0222,500— $00SEC↗
SEKHRI PAUL JDirector D To issuer deriv2024-12-022024-12-0225,461— $00SEC↗
SEKHRI PAUL JDirector D To issuer deriv2024-12-022024-12-0212,367— $00SEC↗
SEKHRI PAUL JDirector D To issuer deriv2024-12-022024-12-0212,500— $00SEC↗
SEKHRI PAUL JDirector D To issuer deriv2024-12-022024-12-0222,500— $00SEC↗
Le Goff CorinneDirector D To issuer deriv2024-12-022024-12-0212,367— $00SEC↗
Le Goff CorinneDirector D To issuer deriv2024-12-022024-12-0222,500— $00SEC↗
Le Goff CorinneDirector D To issuer deriv2024-12-022024-12-0212,500— $00SEC↗
Le Goff CorinneDirector D To issuer deriv2024-12-022024-12-0212,367— $00SEC↗
Le Goff CorinneDirector D To issuer deriv2024-12-022024-12-0213,397— $00SEC↗
Lynch CaseyDirector D To issuer deriv2024-12-022024-12-0212,500— $00SEC↗
Lynch CaseyDirector D To issuer deriv2024-12-022024-12-0222,500— $00SEC↗
Lynch CaseyDirector D To issuer deriv2024-12-022024-12-0212,367— $00SEC↗
Lynch CaseyDirector D To issuer deriv2024-12-022024-12-0214,428— $00SEC↗
Lynch CaseyDirector D To issuer deriv2024-12-022024-12-0212,367— $00SEC↗
Lind Kevin RobertPresident and CEO U Tender2024-12-022024-12-02363,740$60.00 $21.82M0SEC↗
Kaye RandallExecutive Vice President & C U Tender2024-12-022024-12-0230,554$60.00 $1.83M0SEC↗
Kaye RandallCMO M Exercise deriv2024-11-192024-11-1930,554— $0175,946SEC↗
Kaye RandallCMO M Exercise2024-11-192024-11-1930,554$6.00 $183.3K48,474SEC↗
Lind Kevin RobertCEO M Exercise deriv2024-11-132024-11-1312,808— $0255,377SEC↗
Lind Kevin RobertCEO M Exercise2024-11-132024-11-1312,808$3.12 $40.0K443,740SEC↗
Lind Kevin RobertCEO G Gift2024-11-132024-11-1380,000— $0363,740SEC↗
Lind Kevin RobertCEO A Award deriv2024-10-252024-10-2922,000— $022,000SEC↗
Roberts BrandiCFO A Award deriv2024-10-252024-10-297,900— $07,900SEC↗
Kaye RandallCMO A Award deriv2024-10-252024-10-299,500— $09,500SEC↗
Kaye RandallCMO M Exercise deriv2024-10-152024-10-1616,667— $096,300SEC↗
Kaye RandallCMO S Sale2024-10-152024-10-1616,667$59.04 $984.0K17,920SEC↗
Kaye RandallCMO M Exercise2024-10-152024-10-1616,667$4.35 $72.5K34,587SEC↗
Kaye RandallCMO M Exercise deriv2024-09-162024-09-1616,666— $0112,967SEC↗
Kaye RandallCMO S Sale2024-09-162024-09-164,200$31.81 $133.6K21,020SEC↗
Kaye RandallCMO S Sale2024-09-162024-09-169,366$30.89 $289.3K25,220SEC↗
Kaye RandallCMO M Exercise2024-09-162024-09-1616,666$4.35 $72.5K34,586SEC↗
Kaye RandallCMO S Sale2024-09-162024-09-161,900$34.04 $64.7K17,920SEC↗
Kaye RandallCMO S Sale2024-09-162024-09-161,200$33.12 $39.7K19,820SEC↗
Kaye RandallCMO M Exercise deriv2024-08-122024-08-1316,667— $0129,633SEC↗
Lind Kevin RobertCEO M Exercise deriv2024-08-122024-08-132,217— $0192,783SEC↗
Lind Kevin RobertCEO M Exercise deriv2024-08-122024-08-1380,265— $0268,185SEC↗
Kaye RandallCMO S Sale2024-08-122024-08-136,191$35.03 $216.9K17,920SEC↗
Kaye RandallCMO S Sale2024-08-122024-08-1310,476$34.55 $361.9K24,111SEC↗
Kaye RandallCMO M Exercise2024-08-122024-08-1316,667$4.35 $72.5K34,587SEC↗
Lind Kevin RobertCEO M Exercise2024-08-122024-08-132,217$4.20 $9.3K430,932SEC↗
Lind Kevin RobertCEO M Exercise2024-08-122024-08-1380,265$3.12 $250.4K428,715SEC↗
Kaye RandallCMO S Sale2024-06-252024-08-13100$20.87 $2.1K0SEC↗
Aurentz VincentDirector A Award deriv2024-05-232024-05-2422,500— $022,500SEC↗
Le Goff CorinneDirector A Award deriv2024-05-232024-05-2422,500— $022,500SEC↗
Lynch CaseyDirector A Award deriv2024-05-232024-05-2422,500— $022,500SEC↗
SCHNEIDER PHILLIP MDirector A Award deriv2024-05-232024-05-2422,500— $022,500SEC↗
SEKHRI PAUL JDirector A Award deriv2024-05-232024-05-2422,500— $022,500SEC↗
Lind Kevin RobertCEO A Award deriv2024-02-082024-02-09332,134— $0332,134SEC↗
Roberts BrandiCFO A Award deriv2024-02-082024-02-0990,580— $090,580SEC↗
Kaye RandallCMO A Award deriv2024-02-082024-02-09107,560— $0107,560SEC↗
Roberts BrandiCFO A Award2024-02-082024-02-0915,090— $015,090SEC↗
Kaye RandallCMO A Award2024-02-082024-02-0917,920— $017,920SEC↗
ARENA PHARMACEUTICALS INCOther S Sale2024-01-252024-01-293,978,540$24.25 $96.48M0SEC↗
Kaye RandallCMO P Buy2024-01-232024-08-13100$24.82 $2.5K100SEC↗
Aurentz VincentDirector A Award deriv2023-05-252023-05-2612,500— $012,500SEC↗
Le Goff CorinneDirector A Award deriv2023-05-252023-05-2612,500— $012,500SEC↗
Lynch CaseyDirector A Award deriv2023-05-252023-05-2612,500— $012,500SEC↗
SCHNEIDER PHILLIP MDirector A Award deriv2023-05-252023-05-2612,500— $012,500SEC↗
SEKHRI PAUL JDirector A Award deriv2023-05-252023-05-2612,500— $012,500SEC↗
Tiller JaneDirector A Award deriv2023-05-252023-05-2612,500— $012,500SEC↗
Lind Kevin RobertCEO A Award deriv2023-02-092023-02-10325,850— $0325,850SEC↗
Kaye RandallCMO A Award deriv2023-02-092023-02-10146,300— $0146,300SEC↗
Roberts BrandiCFO A Award deriv2023-02-092023-02-10119,700— $0119,700SEC↗
Aurentz VincentDirector A Award deriv2022-05-242022-05-3112,367— $012,367SEC↗
Le Goff CorinneDirector A Award deriv2022-05-242022-05-3112,367— $012,367SEC↗
Lynch CaseyDirector A Award deriv2022-05-242022-05-3112,367— $012,367SEC↗
SCHNEIDER PHILLIP MDirector A Award deriv2022-05-242022-05-3112,367— $012,367SEC↗
SEKHRI PAUL JDirector A Award deriv2022-05-242022-05-3112,367— $012,367SEC↗
Tiller JaneDirector A Award deriv2022-05-242022-05-3112,367— $012,367SEC↗
Kaye RandallCMO A Award deriv2022-03-212022-03-21206,500— $0206,500SEC↗
Perera PhilipCMO A Award deriv2022-02-092022-02-1195,000— $095,000SEC↗
Roberts BrandiCFO A Award deriv2022-02-092022-02-1190,000— $090,000SEC↗
Lind Kevin RobertCEO A Award deriv2022-02-092022-02-11195,000— $0195,000SEC↗
Tiller JaneDirector A Award deriv2021-11-152021-11-1712,367— $012,367SEC↗
Tiller JaneDirector A Award deriv2021-11-152021-11-175,152— $05,152SEC↗
Aurentz VincentDirector A Award deriv2021-09-142021-09-1412,367— $012,367SEC↗
Aurentz VincentDirector A Award deriv2021-09-142021-09-147,214— $07,214SEC↗
ARENA PHARMACEUTICALS INC10% Owner C Conversion deriv2021-03-162021-03-18100,000— $00SEC↗
ARENA PHARMACEUTICALS INC10% Owner C Conversion2021-03-162021-03-18138,000— $03,978,540SEC↗
Lynch CaseyDirector A Award deriv2021-03-112021-03-1114,428— $014,428SEC↗
Lynch CaseyDirector A Award deriv2021-03-112021-03-1112,367— $012,367SEC↗
Le Goff CorinneDirector A Award deriv2021-03-112021-03-1112,367— $012,367SEC↗
Le Goff CorinneDirector A Award deriv2021-03-112021-03-1113,397— $013,397SEC↗